NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Total Non-Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2013 | |
|---|---|---|---|---|---|
| Total Non-Current Assets | ₹336 Cr | ₹309 Cr | ₹273 Cr | ₹272 Cr | ₹38 Cr |
What is the latest Total Non-Current Assets ratio of NATH BIOGENES (INDIA) ?
| Year | Total Non-Current Assets |
|---|---|
| Mar2025 | ₹336 Cr |
| Mar2024 | ₹309 Cr |
| Mar2023 | ₹273 Cr |
| Mar2022 | ₹272 Cr |
| Mar2013 | ₹38 Cr |
How is Total Non-Current Assets of NATH BIOGENES (INDIA) Trending?
| Years | Total Non-Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹336 Cr | 8.96 | |
| Mar2024 | ₹309 Cr | 13.04 | |
| Mar2023 | ₹273 Cr | 0.46 | |
| Mar2022 | ₹272 Cr | 622.09 | |
| Mar2013 | ₹38 Cr | - | |
Compare Total Non-Current Assets of peers of NATH BIOGENES (INDIA)
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NATH BIOGENES (INDIA) | ₹276.2 Cr | 2.4% | -4.4% | -18.8% | Stock Analytics | |
| BOMBAY BURMAH TRADING CORPORATION | ₹11,983.7 Cr | -0.9% | -8.5% | -20.8% | Stock Analytics | |
| KAVERI SEED COMPANY | ₹4,817.8 Cr | 14.6% | -1.3% | -4.4% | Stock Analytics | |
| VENKYS (INDIA) | ₹2,160.3 Cr | 3.7% | 3% | -9.9% | Stock Analytics | |
| BOMBAY SUPER HYBRID SEEDS | ₹935.1 Cr | -4.2% | -15.7% | -36.5% | Stock Analytics | |
| INDO US BIOTECH | ₹252.9 Cr | 6.6% | 0.6% | -41% | Stock Analytics | |
NATH BIOGENES (INDIA) Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NATH BIOGENES (INDIA) | 2.4% |
-4.4% |
-18.8% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses